
Hong Kong Asia Heart Centre (Wuhan Asia Heart Hospital)
Hong Kong Asia Medical Group originated in 1999. Since the establishment of its first hospital, Wuhan Asia Heart Hospital, it has been at the forefront of the development of cardiovascular disciplines.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
* | $400m | Series D | |
Total Funding | 000k |
Related Content
Hong Kong Asia Medical Group, which originated in 1999 with the establishment of its first hospital, Wuhan Asia Heart Hospital, has become a significant player in the cardiovascular healthcare sector in China. The hospital was founded by Tse Chun-ming.
Wuhan Asia Heart Hospital, a tertiary cardiology hospital, was established on November 11, 1999. The hospital has a capacity of 750 beds and provides a comprehensive range of services for cardiovascular diseases. These services include cardiac health check-ups, consultations, and advanced surgical procedures like angioplasty. The institution has gathered a team of domestic cardiovascular disease diagnosis and treatment experts, enabling it to perform a variety of complex cardiac operations.
A key milestone for the hospital was in January 2018, when it passed the evaluation for a Class A hospital in China. The group has also expanded its footprint by acquiring the Xinjiang Cardio-cerebrovascular Hospital in 2010 and establishing heart partnership centers in various cities between 2015 and 2017. In 2018, the global growth equity firm General Atlantic invested $150 million into the holding company, signaling confidence in its business model of operating specialized cardiovascular hospitals and clinics.
Keywords: cardiovascular healthcare, cardiology, specialized hospital, heart surgery, angioplasty, cardiac consultation, tertiary care, medical group, healthcare investment, China healthcare